Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains.
about
Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infectionTrypanosoma cruzi I and IV stocks from Brazilian Amazon are divergent in terms of biological and medical properties in miceBenznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatmentsTrypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes.Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.Human antiprotozoal therapy: past, present, and future.Impact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi"Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue.Performance of TcI/TcVI/TcII Chagas-Flow ATE-IgG2a for universal and genotype-specific serodiagnosis of Trypanosoma cruzi infection.An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress.Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas diseaseBiodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology.Evaluation of nifurtimox treatment of chronic Chagas disease by means of several parasitological methods.Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations.Current status of Chagas disease chemotherapy.Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence.Long-term comparative pharmacovigilance of orally transmitted Chagas disease: first report.Assessing anti-T. cruzi candidates in vitro for sterile cidality.Highly effective serodiagnosis for Chagas' disease.Trypanosoma cruzi I genotype among isolates from patients with chronic Chagas disease followed at the Evandro Chagas National Institute of Infectious Diseases (FIOCRUZ, Brazil).Myocardial scars correlate with eletrocardiographic changes in chronic Trypanosoma cruzi infection for dogs treated with Benznidazole.Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain.In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon.Accomplishing the genotype-specific serodiagnosis of single and dual Trypanosoma cruzi infections by flow cytometry Chagas-Flow ATE-IgG2a.Trypanosoma cruzi: chemotherapy with benznidazole in mice inoculated with strains from Paraná state and from different endemic areas of Brazil.Genetic characterization of Trypanosoma brucei gambiense and clinical evolution of human African trypanosomiasis in Cote d'IvoireTrypanosoma cruzi: clones isolated from the Colombian strain, reproduce the parental strain characteristics, with ubiquitous histotropism
P2860
Q24194546-01DAD88E-5BE7-4638-BA5D-9A7116613A55Q28486306-E55FBDA9-0B62-454D-99B5-48D3A9D65C18Q28535357-7D75E0D5-AE4F-45E0-B834-87E42510B11AQ34546953-C433A543-FAAA-4638-A1AA-1D8CC7C3A859Q34724956-C0B664D3-1F0B-4B33-A684-E3FC315F821DQ35210866-2CDF9AE9-EE16-44DA-A2C3-72FFA38340DFQ35535171-6B5C5795-B92B-42E2-A787-C99A0EFCAF45Q36094866-FCD636BC-2000-406F-982F-C7E7E2532EE1Q36107611-1FD523FD-81EC-4174-ACE4-C1B5BF8BE394Q36319617-032C72A6-6A02-4426-9FB8-5B35073A262DQ36338129-B0E9D85E-3D2E-4AD0-AF4D-DCF8310634E0Q36668496-A2A126B7-3B93-4722-A2FC-23C506FC3733Q36841825-5D774F2E-EB77-44FA-9E3A-728777F97F0AQ37124216-C8E67A90-DB11-48B8-AE58-F0B9BD3C63C1Q37597052-8D150DD3-DF47-4EA6-93A2-B6667B91EB2AQ37879205-2F961BDE-FC7A-405B-A5BE-B56F6EEFD8F3Q38017721-5B6E742B-F730-4248-A3A5-C711CB82C97AQ38867072-7BAFDE9B-CBB1-4A7A-A99B-7885C1E2CB04Q38929035-2C23F0C1-2C10-47EC-8251-A372F5C84542Q39852524-3227715F-9908-40F6-BA88-DEBF3E77139BQ40284487-64FAD66A-9764-462E-973C-6D158A2E94A2Q43584085-972B9C12-4B33-4770-AFBE-2314CF5D90FFQ43989916-7D8375CC-3687-4009-AD19-6D30032B3436Q44632564-35542A80-AA28-409C-8373-A9ED51594C53Q52692717-8AC6CDCD-9E55-4AB1-99D3-6E03E3D1D7A2Q54131801-BAE90035-C307-4F87-B413-D167A0345A97Q56597612-2E4606BB-545C-4A3A-B803-2B956358F3F5Q58845281-F193C621-F2D9-460E-B633-FF47E7882A36
P2860
Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Specific chemotherapy of Chaga ...... culated with the same strains.
@en
Specific chemotherapy of Chaga ...... culated with the same strains.
@nl
type
label
Specific chemotherapy of Chaga ...... culated with the same strains.
@en
Specific chemotherapy of Chaga ...... culated with the same strains.
@nl
prefLabel
Specific chemotherapy of Chaga ...... culated with the same strains.
@en
Specific chemotherapy of Chaga ...... culated with the same strains.
@nl
P2093
P921
P1476
Specific chemotherapy of Chaga ...... culated with the same strains.
@en
P2093
Andrade SG
Ferriolli Filho F
Luquetti AO
Magalhaes JB
P2860
P304
P356
10.1016/0035-9203(92)90156-7
P577
1992-11-01T00:00:00Z